FAVATA, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 1.532
EU - Europa 618
AS - Asia 347
SA - Sud America 12
OC - Oceania 7
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.524
Nazione #
US - Stati Uniti d'America 1.524
IT - Italia 179
CN - Cina 171
SG - Singapore 93
SE - Svezia 82
IE - Irlanda 79
AT - Austria 64
FR - Francia 58
DE - Germania 44
IN - India 28
GB - Regno Unito 19
FI - Finlandia 16
VN - Vietnam 14
BE - Belgio 12
ES - Italia 12
GR - Grecia 9
JP - Giappone 9
NL - Olanda 9
CZ - Repubblica Ceca 8
UA - Ucraina 8
AU - Australia 7
ID - Indonesia 7
BR - Brasile 6
KR - Corea 6
HK - Hong Kong 5
CA - Canada 4
PL - Polonia 4
RO - Romania 4
DK - Danimarca 3
EC - Ecuador 3
IQ - Iraq 3
MX - Messico 3
PK - Pakistan 3
SN - Senegal 3
TR - Turchia 3
BG - Bulgaria 2
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
PT - Portogallo 2
AR - Argentina 1
BW - Botswana 1
CL - Cile 1
CY - Cipro 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
PE - Perù 1
PR - Porto Rico 1
RU - Federazione Russa 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 2.524
Città #
Chandler 221
Ann Arbor 129
Houston 101
Fairfield 96
Santa Clara 93
Beijing 89
Dublin 78
Torino 78
Singapore 74
Woodbridge 73
Vienna 64
Dearborn 56
Ashburn 44
Villeurbanne 43
Nyköping 38
Fremont 33
Wilmington 31
Cambridge 28
Redwood City 28
Seattle 27
Medford 22
Princeton 22
Boardman 19
Columbus 19
Guangzhou 14
Nanjing 14
New York 13
Jacksonville 9
Turin 9
Brussels 8
Los Angeles 8
Munich 8
Pisa 8
Brno 7
Shanghai 7
Boston 6
Chicago 6
Hefei 6
Jakarta 6
San Diego 6
Catania 5
Helsinki 5
Milan 5
Shenzhen 5
Hong Kong 4
Jinan 4
Mumbai 4
Norwalk 4
Philadelphia 4
Tianjin 4
Toronto 4
Warsaw 4
Washington 4
Zhengzhou 4
Athens 3
Baghdad 3
Boulder 3
Copenhagen 3
Esslingen am Neckar 3
Falkenstein 3
Islamabad 3
Kumar 3
Lebanon 3
Madrid 3
Tarragona 3
Aachen 2
Bengaluru 2
Bury St Edmunds 2
Coimbatore 2
Cosenza 2
Formello 2
Frankfurt Am Main 2
Giussano 2
Guadalupe 2
Hanoi 2
London 2
Long Beach 2
Mountain View 2
Mérignac 2
Nanchang 2
New Orleans 2
Niles 2
Perth 2
Phoenix 2
Quito 2
Rochester 2
Romainville 2
Salford 2
San Mateo 2
Sofia 2
Tappahannock 2
Tokyo 2
Weimar 2
Zurich 2
Almaty 1
Amsterdam 1
Aurora 1
Avezzano 1
Bangalore 1
Baotou 1
Totale 1.798
Nome #
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children 400
Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B 196
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection 144
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics 144
A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples 142
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients 137
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study 117
Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study 116
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma 114
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children 106
Role of simeprevir plasma concentrations in HCV treated patients with dermatological symptoms 105
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs 104
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples 99
Pharmacokinetics of simeprevir and risk of skin reactions in patients with co-infection HIV/HCV with or without a protease inhibitor containing HAART 97
UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma 89
A UHPLC-MS/MS method for the quantification of currently used direct antiviral agents in human plasma and evaluation of "normalized matrix effect" 83
Pharmacogenomic influence on sepsis outcome in critically ill patients 83
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy 77
Development and validation of UHPLC–MS/MS methods for the quantification of colistin in plasma and dried plasma spots 72
Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study 72
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study 66
A UHPLC-MS/MS Method to Quantify Tacrolimus in Tissues: Standardization Based on the Real Volume of Cells 65
Totale 2.628
Categoria #
all - tutte 7.843
article - articoli 0
book - libri 0
conference - conferenze 1.163
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020336 0 0 0 0 0 62 36 27 78 108 10 15
2020/2021233 16 30 9 16 17 16 12 9 26 10 45 27
2021/2022344 16 30 17 18 19 54 20 16 9 14 82 49
2022/2023568 52 57 18 54 49 131 26 44 71 14 31 21
2023/2024183 36 31 5 6 14 17 3 12 0 10 23 26
2024/2025242 6 8 23 39 135 31 0 0 0 0 0 0
Totale 2.628